Delivery Order SPE2DB22D2206-SPE2DB24FJF67
Award Date
7/16/24
Potential Completion Date
8/6/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,912.14 firm fixed-price delivery order is for the drug TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, with a period of performance through December 4, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This federal contract award, valued at $2,283.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tecvayli 30 mg/3 ml vials, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The $23,824.28 firm-fixed-price delivery order has an ultimate completion date of August 13, 2024. This award is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the Defense Logistics Agency (DLA) Troop Support Medical with a Tecvayli 153 mg/1.7 mL vial medication. The $23,824.28 firm fixed-price delivery order has a performance period through September 30, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,736.24, is for the delivery of the specialty medication TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. This is a firm-fixed-price delivery order contract with a completion date of March 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $23,736.24 contract is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 7, 2025. Amerisourcebergen holds a significant...
This federal contract award, valued at $11,868.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a specialty pharmaceutical product, with a period of performance through February 4, 2025. This contract is a firm fixed-price delivery order and is not designated as a set-aside procurement. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, valued at $6,161.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract is a firm-fixed-price delivery order with a period of performance through December 31, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that holds several Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TECVAYLI 30 MG/3 ML VIAL 3ML, a pharmaceutical product. The contract has a ceiling value of $3,479.73 and is a Firm Fixed Price Delivery Order with a period of performance through June 20, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $35,957 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of TECVAYLI 153 MG/1.7 ML vials. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 2023. No set-aside designation was applied. As a prime contractor supporting DLA medical supply programs, Amerisourcebergen routinely...